News

Deal Announcements

Lycera Garners $36 Million Series A Round

Tuesday, April 21, 2009 5:51:00 AM PDT | VentureDeal Staff
Plymouth, Michigan  --  Pharmaceutical company Lycera has secured $36 million in its first round of venture capital funding.

Lycera is is developing proprietary small molecule technologies to treat immune disorders.

Arch Venture Partners and Clarus Ventures led the round, which also included EDF Ventures and InterWest Partners.proceeds purposes from the financing were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1